Effects of locally administration of argatroban using a hydrogel-coated balloon catheter on intimal thickening induced by balloon injury

Japanese Circulation Journal

Volumn 61, Issue 3, 1997, Pages 256-262

  Imanishi, Toshio ^a   Arita, Mikio ^a   Hamada, Masanori ^a   Tomobuchi, Yoshiaki ^a   Hano, Takuzo ^a   Nishio, Ichiro ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Argatroban; Hydrogel coated balloon catheter; Local delivery

Indexed keywords

ARGATROBAN;

ANIMAL EXPERIMENT; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; BALLOON CATHETER; COMMON CAROTID ARTERY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG UPTAKE; NONHUMAN; RABBIT; REGIONAL PERFUSION; THROMBOCYTE ACTIVATION; VASCULAR ENDOTHELIUM;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; ANTITHROMBINS; BLOOD PLATELETS; CAROTID ARTERY INJURIES; CAROTID ARTERY, COMMON; DRUG DELIVERY SYSTEMS; HYDROGEL; HYPERPLASIA; PIPECOLIC ACIDS; POLYETHYLENE GLYCOLS; RABBITS; TUNICA INTIMA;

EID: 0030986926     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.61.256     Document Type: Article

References (35)

1. Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Ueno K, Yokoi H et al: Restenosis after successful percutaneous transluminal coronary angioplasty; serial angiographic follow-up of 220 patients. J Am Coll Cardiol 1988; 12: 616-623
2. Serruys PW, Luijiten HE, Beatt KJ, Geuskens R, De Feyter PJ, Van Den Brand M et al: Incidence of restenosis after successful coronary angioplasty: a time related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, and 3 months. Circulation 1988; 77: 361-372
3. Corcos T, David PR, Val PG, Renkin J, Dangiosse V, Rapold HG, Bourassa MG: Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 1985; 109: 926-931
4. Schwartz L, Bourassa MG, Lesperance J, Aldridge HE, Kazim F, Salvatori VA et al: Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal angioplasty. N Engl J Med 1988; 318: 1714-1719
5. Reis GJ, Boucher TM, Sipperly ME, Silverman DI, McCabe CH, Bairn DS et al: Randomized trial of fish oil for the prevention of restenosis after coronary angioplasty. Lancet 1989; 2: 177-181
6. Gasic GP, Arenas CP, Gasic TB, Gasic GJ: Coagulation factor X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells. Proc Natl Acad Sci USA 1992; 89: 2317-2320
7. Ragosta M, Gimple LW, Gertz SD, Dunwiddie CT, Vlasuk GP, Haber HL et al: Specific factor Xa inhibition reduces restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circulation 1994; 89: 1262-1271
8. Sarembock IJ, Gertz SD, Gimple LW, Owen RM, Powers ER, Roberts WC: Effectiveness of recombinant desulfatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circulation 1991; 84: 232-243
9. Nemerson Y: Tissue factor and hemostasis. Blood 1988; 71: 1-8
10. Rapaport SI, Rao LV: Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb 1992; 12: 1111-1121
11. Annex BH, Denning SM, Channon KM, Sketch Jr MH, Stack RS, Morrissey JH et al: Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation 1995; 91: 619-622
12. Bar-Shavit R, Kahn A, Wilner GD, Fenton JW: Monocyte chemotaxis: stimulation by specific exocite region in thrombin. Science 1983; 220: 728-731
13. Bar-Shavit R, Benezia M, Eldos A, Hyam E, Fenton JW, Wilter GD et al: Thrombin immobilized to extracellular matrix is a potent mitogen for vascular smooth muscle cells. Cell Reg 1990; 1: 453-463
14. McNamara CA, Sarembock IJ, Gimple LW, Fenton JW, Coughlin SR, Owens GK: Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest 1993; 91: 94-98
15. Powers JC, Kam CM: Synthetic substrates and inhibitors thrombin. In: Berliner LJ, editor. Thrombin: structure and function. New York: Plenum Press; 1992; 117-158
16. Okamoto S, Hijikata A: Potent inhibition of thrombin by the newly synthesized arginine derivative no. 805: the importance of sterestructure of its hydrophobic carboxamide portion. Biochem Biophys Res Commun 1981; 101: 440-446
17. Wolinsky H, Thung SN: Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery. J Am Coll Cardiol 1990; 15: 475-481
18. Riessen R, Rahimidadeh H, Blessing E, Takeshita S, Barry JJ, Isner JM: Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloon. Hum Gene Ther 1993; 4: 749-758
19. Fuster V, Badimon L, Badimon JJ, Chesebro JH: The pathogenesis of coronary disease and the acute coronary syndrome. N Engl J Med 1992; 326: 242-250
20. Heras M, Chesebro JH, Webster MWI, Mruk JS, Grill DE, Penny WJ et al: Hirudin, heparin, and placebo during deep arterial injury in the pig: the in vivo role of thrombin in platelet-mediated thrombosis. Circulation 1990; 82: 1476-1484
21. Sarembock IJ, Gertz SD, Gimple LW, Owen RM, Powers ER, Roberts WC: Effectiveness of recombinant desulphathohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circulation 1991; 84: 232-243
22. Nicolas AN, Scott JS, Julile O, Thien-Khai H, Israel FC, Shaun RC: Thrombin receptor expression in normal and atherosclerotic human arteries. J Clin Invest 1992; 90: 1614-1621
23. Josiah NW, Jose R, Romesh S, Jeremy O, Chizheng Z, David JH et al: Characterization of thrombin receptor expression during vascular lesion formation. Circ Res 1994; 75: 1029-1038
24. Edelman ER, Adams DA, Karnovsky MJ: Effects of controlled adventitial heparin delivery on smooth muscle proliferation following endothelial injury. Proc Natl Acad Sci USA 1990; 87: 3773-3777
25. Ellis SG, Roubin GS, Wilentz J, Liu S, Douglas JS, King III SB: Effect of 18-to 24-h heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J 1989; 117: 777-782
26. Schwartz L, Bourassa MG, Lesperance J, Aldridge HE, Kazim F, Salvatori VA et al: Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal angioplasty. N Engl J Med 1988; 318: 1714-1719
27. Powell JS, Clozel JP, Muller RKM, Kuhn H, Hefti F, Hosang M et al: Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989; 245: 186-188
28. Serruys PW, Hermans WRM: The new angiotensin converting enzyme inhibitor cilazapril dose not prevent restenosis after coronary angioplasty: the results of the MERCATOR trial (abstract). J Am Coll Cardiol 1992; 19: 258A
29. Lam JYT, Lacoste L, Bourassa MG: Cilazapril and early atherosclerotic changes after balloon injury of porcine carotid arteries. Circulation 1992; 85: 1542-1547
30. Gelman J, Ezekowitz MD, Sarembock IJ, Azrin MA, Nochomovitz L, Lerner E et al: The effect of lovastatin on intimal hyperplasia after balloon angioplasty: a study in an atherosclerotic hypercholesterolemic rabbits. J Am Coll Cardiol 1991; 17: 251-259
31. Chobanian AV, Haudenschild CC, Nickerison C, Drago R: Antiatherogenic effect of captopril in Watanabe heritable hyperlipidemic rabbit. Hypertension 1990; 15: 327-331
32. Bauters C, DeGroote P, Adamantktis Z, Delcayre C, Hamon M, Lablanche M et al: Protooncogene expression in rabbit aorta after wall injury: first marker of the cellular process loading to restenosis after angioplasty. Eur Heart J 1991; 14: 556-559
33. Miano JM, Tota RR, Vlasic N, Danishefsky KJ, Stemerman MB: Early protooncogene expression in rat aortic smooth muscle cells following endothelial removal. Am J Pathol 1990; 137: 761-765
34. Serruys PW, Herman JPR, Simon R, Rutsch W, Bode C, Laarman GJ et al: A comparison of hirudin with heparin in the prevention of restenosis after angioplasty. N Engl J Med 1995; 333: 757-763
35. Bitll JA, Stony J, Brinker JA, Ahmed WH, Meckel CR, Chaitman BR et al: Treatment with bivalirudin (hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. N Engl J Med 1995; 333: 764-769